Detalhe da pesquisa
1.
Cost-effectiveness of pharmacogenomic-guided treatment for major depression.
CMAJ
; 195(44): E1499-E1508, 2023 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37963621
2.
Costs of major depression covered / not covered in British Columbia, Canada.
BMC Health Serv Res
; 23(1): 1446, 2023 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38124043
3.
A Canadian Simulation Model for Major Depressive Disorder: Study Protocol.
Pharmacoecon Open
; 8(3): 493-505, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38528312
4.
Evaluating treatment outcomes in pharmacogenomic-guided care for major depression: A rapid review and meta-analysis.
Psychiatry Res
; 321: 115102, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36780865
5.
Collaborating with Patient Partners to Model Clinical Care Pathways in Major Depressive Disorder: The Benefits of Mixing Evidence and Lived Experience.
Pharmacoeconomics
; 40(10): 971-977, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35877043
6.
The Risk of Relapse of Depression During Pregnancy After Discontinuation of Antidepressants: A Systematic Review and Meta-Analysis.
J Clin Psychiatry
; 81(4)2020 06 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32558401